| Title |
Author |
Type |
Date |
Words |
| Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial. |
|
|
Jul 24, 2024 |
331 |
| Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial. |
|
|
Jul 24, 2024 |
328 |
| Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial. |
|
|
Jul 24, 2024 |
332 |
| LATEST COMPANY NEWS. |
|
|
Jul 23, 2024 |
12525 |
| LATEST COMPANY NEWS. |
|
|
Jul 23, 2024 |
13645 |
| Valneva receives CEPI funding to boost access to world's first chikungunya vaccine. |
|
|
Jul 22, 2024 |
171 |
| Valneva receives CEPI funding to boost access to world's first chikungunya vaccine. |
|
|
Jul 22, 2024 |
170 |
| Genentech announces two-year data from Pagoda, Pavilion studies. |
|
|
Jul 18, 2024 |
633 |
| LATEST COMPANY NEWS. |
|
|
Jul 17, 2024 |
16583 |
| Genentech announces results from two arms of CT-996 trial. |
|
Financial report |
Jul 17, 2024 |
194 |
| Shs 806.3bn bailout: Dei Biopharma, Roko benefit. |
Serugo, Geoffrey |
|
Jul 17, 2024 |
1600 |
| Genentech reports positive Phase I Results for oral GLP-1 agonist CT-996. |
|
|
Jul 17, 2024 |
284 |
| Genentech reports positive Phase I Results for oral GLP-1 agonist CT-996. |
|
|
Jul 17, 2024 |
283 |
| Gilead Sciences, Cigalah Healthcare in extended tie-up. |
|
|
Jul 17, 2024 |
259 |
| LATEST COMPANY NEWS. |
|
|
Jul 16, 2024 |
8538 |
| HanAll Biopharma names new chief business development and legal officer. |
|
|
Jul 16, 2024 |
161 |
| HanAll Biopharma names new chief business development and legal officer. |
|
|
Jul 16, 2024 |
160 |
| Relay Therapeutics announces termination of license agreement with Genentech. |
|
|
Jul 16, 2024 |
199 |
| LATEST COMPANY NEWS. |
|
|
Jul 16, 2024 |
13087 |
| LATEST COMPANY NEWS. |
|
|
Jul 16, 2024 |
12365 |
| LATEST COMPANY NEWS. |
|
|
Jul 15, 2024 |
19778 |
| Benitec Biopharma's BB-301 shows efficacy in Phase 1b/2a study of OPMD. |
|
|
Jul 15, 2024 |
263 |
| Repligen says unauthorized third party accessed files in its info systems. |
|
|
Jul 15, 2024 |
193 |
| Milestone as HIV prevention drug proves safe, effective in clinical trial. |
|
|
Jul 13, 2024 |
680 |
| IAS announces 2024 Me and My Healthcare Provider Campaign Champions to honour outstanding stigma-free services. |
|
|
Jul 12, 2024 |
483 |
| Spine BioPharma, signs agreement with Ensol BioSciences. |
|
|
Jul 11, 2024 |
657 |
| Spine BioPharma, signs agreement with Ensol BioSciences. |
|
|
Jul 11, 2024 |
656 |
| Can-Fite BioPharma applies for FDA Orphan Drug Designation for namodenoson. |
|
|
Jul 11, 2024 |
180 |
| Twist Bioscience announces launch of CHO Express Antibodies. |
|
|
Jul 10, 2024 |
158 |
| LATEST COMPANY NEWS. |
|
|
Jul 9, 2024 |
12646 |
| LATEST COMPANY NEWS. |
|
|
Jul 9, 2024 |
13626 |
| U.S. to pay Moderna $176M for flu vaccine. |
Associated Press |
|
Jul 8, 2024 |
212 |
| Immix Biopharma doses first patient in U.S. AL amyloidosis trial with NXC-201. |
|
|
Jul 8, 2024 |
200 |
| Moderna, Mitsubishi Tanabe enter joint pact to promote mRNA vaccine in Japan. |
|
|
Jul 8, 2024 |
191 |
| Kalangala community urges govt to make new HIV drug available. |
|
|
Jul 8, 2024 |
543 |
| EU grants Ghana pound 32m to develop pharmaceutical industry. |
|
|
Jul 6, 2024 |
536 |
| Genentech gains FDA approval for Vabysmo prefilled syringe in treating causes of vision loss. |
|
|
Jul 5, 2024 |
160 |
| Genentech gains FDA approval for Vabysmo prefilled syringe in treating causes of vision loss. |
|
|
Jul 5, 2024 |
161 |
| HIV breakthrough: New drug 100% effective against infection. |
|
|
Jul 4, 2024 |
1108 |
| LATEST COMPANY NEWS. |
|
|
Jul 2, 2024 |
13880 |
| Biogen acquires HI-Bio, enhances immunology pipeline. |
|
|
Jul 2, 2024 |
162 |
| Biogen acquires HI-Bio, enhances immunology pipeline. |
|
|
Jul 2, 2024 |
158 |
| Biogen acquires HI-Bio, enhances immunology pipeline. |
|
|
Jul 2, 2024 |
161 |
| ZENAS BIOPHARMA NAMES ORLANDO OLIVEIRA AS CHIEF COMMERCIAL OFFICER. |
|
|
Jul 2, 2024 |
254 |
| ZENAS BIOPHARMA APPOINTS ORLANDO OLIVEIRA AS CHIEF COMMERCIAL OFFICER. |
|
|
Jul 2, 2024 |
158 |
| LATEST COMPANY NEWS. |
|
|
Jul 2, 2024 |
12611 |
| LATEST COMPANY NEWS. |
|
|
Jul 1, 2024 |
20596 |
| Argent BioPharma raises USD500,000 in new funding. |
|
|
Jul 1, 2024 |
178 |
| Argent BioPharma raises USD500,000 in new funding. |
|
|
Jul 1, 2024 |
177 |
| Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases. |
Misra, Kaalindi; Sleczkowska, Milena; Santoro, Silvia; Gerrits, Monique M.; Mascia, Elisabetta; Marc |
Report |
Jul 1, 2024 |
8428 |
| Dynavax Technologies commences dosing in Z-1018 phase 1/2 clinical trial. |
|
|
Jun 28, 2024 |
188 |
| Dynavax Technologies commences dosing in Z-1018 phase 1/2 clinical trial. |
|
|
Jun 28, 2024 |
189 |
| LATEST COMPANY NEWS. |
|
|
Jun 27, 2024 |
36078 |
| Biogen's Lecanemab launched in China to treat Alzheimer's Disease. |
|
|
Jun 27, 2024 |
189 |
| Biogen's Lecanemab launched in China to treat Alzheimer's Disease Use symbol Eisai. |
|
|
Jun 27, 2024 |
189 |
| Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds. |
|
|
Jun 26, 2024 |
564 |
| Injectable HIV drug trial returns promising results. |
|
|
Jun 26, 2024 |
883 |
| FDA urged to approve 2nd generation dengue vax. |
|
|
Jun 25, 2024 |
532 |
| LATEST COMPANY NEWS. |
|
|
Jun 25, 2024 |
13187 |
| LATEST COMPANY NEWS. |
|
|
Jun 25, 2024 |
12636 |
| Valmet to supply advanced tissue machine to Andhra Paper Limited in India. |
|
|
Jun 25, 2024 |
186 |
| Valmet to supply advanced tissue machine to Andhra Paper Limited in India. |
|
|
Jun 25, 2024 |
185 |
| Tonix Pharmaceuticals presents vaccine platform data at Vaccine Congress 2024. |
|
|
Jun 25, 2024 |
403 |
| 'Ian Khama seems to know a lot about poisoning' - Botswana's Masisi. |
|
|
Jun 25, 2024 |
1686 |
| FDA urged to approve 2nd generation dengue vax. |
|
|
Jun 25, 2024 |
532 |
| Matinas BioPharma reports treatment of patient with mucor infection with MAT2203. |
|
|
Jun 24, 2024 |
169 |
| Court orders SK chief's estranged wife to vacate art center at group headquarters. |
|
|
Jun 21, 2024 |
438 |
| MorphoSys and Novartis sign delisting agreement. |
|
|
Jun 20, 2024 |
306 |
| Findings from the First Year of a Federally Funded, Direct-to-Consumer HIV Self-Test Distribution Program--United States, March 2023-March 2024. |
Sanchez, Travis; MacGowan, Robin J.; Hecht, Jennifer; Keralis, Jessica M.; Ackah-Toffey, Lucinda; Bo |
Survey |
Jun 20, 2024 |
6329 |
| Aytu BioPharma announces paydown, refinancing of term loan. |
|
|
Jun 18, 2024 |
390 |
| LATEST COMPANY NEWS. |
|
|
Jun 18, 2024 |
9897 |
| LATEST COMPANY NEWS. |
|
|
Jun 18, 2024 |
13219 |
| REDWIRE PIONEERING BIOPHARMA PRODUCTION IN SPACE. |
|
|
Jun 18, 2024 |
540 |
| Assembly Biosciences announces $12.6M in equity financings. |
|
|
Jun 17, 2024 |
227 |
| Roche's Genentech announces results from Phase III STARGLO study. |
|
|
Jun 16, 2024 |
334 |
| Namibian first ladies call for new HIV medicine. |
|
|
Jun 13, 2024 |
891 |
| Vaksindo inaugurates veterinary vaccine factory in Hung Yen. |
|
|
Jun 13, 2024 |
250 |
| Palatin Technologies initiates Phase 2 bremelanotide clinical study to treat obesity. |
|
Clinical report |
Jun 13, 2024 |
315 |
| Palatin Technologies initiates Phase 2 bremelanotide clinical study to treat obesity. |
|
Clinical report |
Jun 13, 2024 |
316 |
| Vaksindo inaugurates veterinary vaccine factory in HAEdegng Yen. |
|
|
Jun 12, 2024 |
206 |
| Vaksindo inaugurates veterinary vaccine factory in HAEdegng Yen. |
|
|
Jun 12, 2024 |
267 |
| Palatin announces initiation of Phase 2 clinical study of bremelanotide. |
|
Clinical report |
Jun 12, 2024 |
258 |
| LATEST COMPANY NEWS. |
|
|
Jun 11, 2024 |
10208 |
| LATEST COMPANY NEWS. |
|
|
Jun 11, 2024 |
14083 |
| LATEST COMPANY NEWS. |
|
|
Jun 11, 2024 |
12470 |
| Arcus Biosciences announces completion of enrollment in Phase 3 trial for domvanalimab regimen in upper GI cancers. |
|
|
Jun 10, 2024 |
260 |
| Arcus Biosciences announces completion of enrollment in Phase 3 trial for domvanalimab regimen in upper GI cancers. |
|
|
Jun 10, 2024 |
256 |
| Arcus completes enrollment for domvanalimab study for GI cancer. |
|
|
Jun 10, 2024 |
178 |
| Arcus Biosciences announces completion of enrollment in Phase 3 trial for domvanalimab regimen in upper GI cancers. |
|
|
Jun 10, 2024 |
259 |
| Africa CDC, AU Pledges Support For Gavi Unveiling. |
|
|
Jun 10, 2024 |
439 |
| Eisai, Biogen say FDA accepted sBLA for monthly LEQEMBI IV maintenance dosing. |
|
|
Jun 9, 2024 |
209 |
| Five-year data for Genentech's Evrysdi show ability of children to sit, stand. |
|
|
Jun 7, 2024 |
263 |
| Arbutus Biopharma announces new data from IM-PROVE trial. |
|
|
Jun 5, 2024 |
422 |
| Can-Fite BioPharma announces update on Namodenoson. |
|
|
Jun 5, 2024 |
268 |
| Gilead's seladelpar shows strong two-year efficacy and safety in primary biliary cholangitis. |
|
|
Jun 5, 2024 |
286 |
| Gilead's seladelpar shows strong two-year efficacy and safety in primary biliary cholangitis. |
|
|
Jun 5, 2024 |
282 |
| Gilead's seladelpar shows strong two-year efficacy and safety in primary biliary cholangitis. |
|
|
Jun 5, 2024 |
285 |
| BioNTech names three 'priority' areas after securing Rwf180bn funding. |
|
|
Jun 4, 2024 |
551 |
| LATEST COMPANY NEWS. |
|
|
Jun 4, 2024 |
13293 |
| LATEST COMPANY NEWS. |
|
|
Jun 4, 2024 |
12515 |
| LATEST COMPANY NEWS. |
|
|
Jun 4, 2024 |
12425 |
| Cue Biopharma presents updated data from Phase 1 trial of CUE-101. |
|
|
Jun 4, 2024 |
324 |
| Cyclacel Pharmaceuticals announces presentation of data on fadraciclib. |
|
|
Jun 4, 2024 |
189 |
| Gilead reached agreement in principle to resolve federal TDF litigation. |
|
|
Jun 4, 2024 |
315 |
| Cyclacel: Data from fadraciclib monotherapy studies support ongoing POC study. |
|
|
Jun 3, 2024 |
380 |
| Gilead, Arcus announce data supporting ongoing Phase 3 STAR-221 study. |
|
|
Jun 2, 2024 |
220 |
| Gilead, Arcus announce new data from Cohort B of ARC-9 mCRC study. |
|
|
Jun 2, 2024 |
205 |
| Sequence-Based Viscosity Prediction for Rapid Antibody Engineering. |
Estes, Bram; Jain, Mani; Jia, Lei; Whoriskey, John; Bennett, Brian; Hsu, Hailing |
|
Jun 1, 2024 |
5635 |
| Development of a Plant-Expressed Subunit Vaccine against Brucellosis. |
Rutkowska, Daria A.; Du Plessis, Lissinda H.; Suleman, Essa; O’Kennedy, Martha M.; Thimiri Govinda R |
|
Jun 1, 2024 |
11940 |
| Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty[sup.®]. |
König, Brigitte; Kirchner, Jürgen O. |
|
Jun 1, 2024 |
4667 |
| mRNA Technology and Mucosal Immunization. |
Toniolo, Antonio; Maccari, Giuseppe; Camussi, Giovanni |
Report |
Jun 1, 2024 |
10800 |
| Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. |
Malme, Kristian Braathen; Stene-Johansen, Kathrine; Klundby, Ingvild; Backe, Øystein; Foshaug, Tarje |
Report |
Jun 1, 2024 |
7229 |
| Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection. |
Crobu, Maria Grazia; Ravanini, Paolo; Impaloni, Clotilde; Martello, Claudia; Bargiacchi, Olivia; Di |
Report |
Jun 1, 2024 |
8628 |
| Investigation of Respiratory Pathogens Responsible for Coinfection in COVID-19 Patients/COVID-19 Hastalarinda Koinfeksiyondan Sorumlu Etkenlerin Arastirilmasi. |
Salar-Gul, Sabiha; Ciftci, Nurullah; Turk-Dagi, Hatice; Arslan, Ugur |
|
Jun 1, 2024 |
4331 |
| Effect of High Molybdenum Diet on Copper Status, Growth Performance, Blood Metabolites, Select Liver and Kidney Minerals, and Immune Responses of Boer Crosses. |
Solaiman, Sandra G.; Beguesse, Kyla A.; Min, Byeng R. |
|
Jun 1, 2024 |
7918 |
| BioNTech's vaccine plant in Rwanda gets over Rwf180bn boost. |
|
|
May 31, 2024 |
683 |
| Gilead says Phase 3 TROPiCS-04 study did not meet primary endpoint. |
|
|
May 30, 2024 |
231 |
| LATEST COMPANY NEWS. |
|
|
May 30, 2024 |
35533 |
| Tunisia, WHO seek scaled-up cooperation in pharmaceuticals, vaccine production. |
|
|
May 30, 2024 |
202 |
| Tunisia, WHO seek scaled-up cooperation in pharmaceuticals, vaccine production. |
|
|
May 29, 2024 |
154 |
| Tunisia, WHO seek scaled-up cooperation in pharmaceuticals, vaccine production. |
|
|
May 29, 2024 |
162 |
| VBI Vaccines announces new tumor response data from study of VBI-1901 in GBM. |
|
Clinical report |
May 29, 2024 |
177 |
| Turn Biotechnologies signs global licensing agreement with HanAll Biopharma. |
|
|
May 29, 2024 |
189 |
| Turn Biotechnologies signs global licensing agreement with HanAll Biopharma. |
|
|
May 29, 2024 |
190 |
| LATEST COMPANY NEWS. |
|
|
May 28, 2024 |
12608 |
| LATEST COMPANY NEWS. |
|
|
May 28, 2024 |
13887 |
| YS Biopharma Co changes name to LakeShore Biopharma Co, Ltd. |
|
|
May 27, 2024 |
195 |
| YS Biopharma Co changes name to LakeShore Biopharma Co, Ltd. |
|
|
May 27, 2024 |
196 |
| UNICEF and Gavi Urged to Boost Malaria Vaccine Orders. |
|
|
May 26, 2024 |
827 |
| AbbVie acquires Landos Biopharma. |
|
|
May 24, 2024 |
186 |
| AbbVie acquires Landos Biopharma. |
|
|
May 24, 2024 |
185 |
| It's Time Our Government Apologized Over The Covid Vaccine. |
|
|
May 23, 2024 |
490 |
| Swixx Biopharma Acquires Colombia-Based Biopas to Expand to Latin America. |
|
|
May 23, 2024 |
224 |
| Swixx Biopharma Acquires Colombia-Based Biopas to Expand to Latin America. |
|
|
May 23, 2024 |
199 |
| Biogen to acquire Human Immunology Biosciences for $1.15B upfront. |
|
|
May 22, 2024 |
411 |
| FDA grants Breakthrough Therapy Designation to Genentech's inavolisib for advanced breast cancer. |
|
|
May 21, 2024 |
209 |
| GC Biopharma and Novel Pharma secure FDA IND clearance for Sanfilippo Syndrome treatment. |
|
|
May 21, 2024 |
175 |
| FDA grants Breakthrough Therapy Designation to Genentech's inavolisib for advanced breast cancer. |
|
|
May 21, 2024 |
210 |
| GC Biopharma and Novel Pharma secure FDA IND clearance for Sanfilippo Syndrome treatment. |
|
|
May 21, 2024 |
176 |
| GT Biopharma to sell 740,000 shares at $4.35 in registered direct offering. |
|
|
May 21, 2024 |
171 |
| LATEST COMPANY NEWS. |
|
|
May 21, 2024 |
12339 |
| LATEST COMPANY NEWS. |
|
|
May 21, 2024 |
13116 |
| Nature Communications publishes data on CSL and Arcturus Therapeutics' COVID-19 vaccine. |
|
|
May 20, 2024 |
200 |
| Nature Communications publishes data on CSL and Arcturus Therapeutics' COVID-19 vaccine. |
|
|
May 20, 2024 |
199 |
| Plan to set up multi-million shilling vaccine plant in top gear. |
|
|
May 19, 2024 |
273 |
| Regulus Therapeutics promotes Rekha Garg, MD, MS to chief medical officer. |
|
|
May 17, 2024 |
187 |
| Regulus Therapeutics promotes Rekha Garg, MD, MS to chief medical officer. |
|
|
May 17, 2024 |
188 |
| Takeda's dengue vaccine approved for use in Viet Nam. |
|
|
May 16, 2024 |
405 |
| Kenya to get World Bank's Sh130 billion for vaccines factory. |
|
|
May 16, 2024 |
556 |
| LATEST COMPANY NEWS. |
|
|
May 16, 2024 |
34689 |
| Ionis and Biogen cease development of BIIB105 for ALS following Phase 1/2 study. |
|
|
May 16, 2024 |
172 |
| First Wave BioPharma rebrands to Entero Therapeutics ahead of Phase 3 trial for latiglutenase. |
|
|
May 16, 2024 |
185 |
| Novartis finalises acquisition of MorphoSys AG at EUR68 per share. |
|
|
May 16, 2024 |
166 |
| Ionis and Biogen cease development of BIIB105 for ALS following Phase 1/2 study. |
|
|
May 16, 2024 |
176 |
| Accenture invests in Turbine to boost AI-powered cell simulations for biopharma R&D. |
|
|
May 16, 2024 |
192 |
| First Wave BioPharma rebrands to Entero Therapeutics ahead of Phase 3 trial for latiglutenase. |
|
|
May 16, 2024 |
184 |
| Novartis finalises acquisition of MorphoSys AG at EUR68 per share. |
|
|
May 16, 2024 |
165 |
| Ionis and Biogen cease development of BIIB105 for ALS following Phase 1/2 study. |
|
|
May 16, 2024 |
175 |
| Genentech announces results from CT-388 clinical trial. |
|
Financial report |
May 16, 2024 |
201 |
| Novartis meets all tender offer conditions to acquire MorphoSys. |
|
|
May 16, 2024 |
240 |
| Matinas BioPharma announces new in vitro data on use of LNCs. |
|
|
May 16, 2024 |
177 |
| First Wave BioPharma changes name to Entero Therapeutics. |
|
|
May 16, 2024 |
274 |
| Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development. |
|
|
May 16, 2024 |
261 |
| LATEST COMPANY NEWS. |
|
|
May 15, 2024 |
16953 |
| WHO prequalifies new dengue vaccine by Japanese company. |
|
|
May 15, 2024 |
320 |
| Dei Biopharma breaks ground, gets approval to make drugs. |
|
|
May 15, 2024 |
618 |
| LATEST COMPANY NEWS. |
|
|
May 14, 2024 |
16112 |
| LATEST COMPANY NEWS. |
|
|
May 14, 2024 |
12353 |
| Eisai/Biogen initiate FDA BLA for LEQEMBI. |
|
|
May 14, 2024 |
169 |
| Tetanus injection not available in market. |
|
|
May 13, 2024 |
175 |
| NDA gives Dei Biopharma nod to start drug manufacturing. |
|
|
May 13, 2024 |
470 |
| Giants AstraZeneca withdraws Covid-19 jab from the market. |
|
|
May 10, 2024 |
356 |
| Immix Biopharma announces NXC-201 relapsed/refractory AL Amyloidosis data. |
|
|
May 10, 2024 |
265 |
| AstraZeneca begins worldwide withdrawal of COVID-19 vaccine. |
|
|
May 9, 2024 |
282 |
| AstraZeneca to withdraw its Covid vaccine worldwide amid concerns over side effects. |
|
|
May 9, 2024 |
306 |
| Aeon Biopharma provides update on development pipeline. |
|
|
May 9, 2024 |
210 |
| AstraZeneca begins worldwide withdrawal of COVID-19 vaccine. |
|
|
May 8, 2024 |
862 |
| JUST IN: COVID-19 vaccine withdrawn by producer due to dangerous side effects. |
|
|
May 8, 2024 |
368 |
| LATEST COMPANY NEWS. |
|
|
May 7, 2024 |
12366 |
| LATEST COMPANY NEWS. |
|
|
May 7, 2024 |
17938 |
| HanAll Biopharma initiates Phase III VELOS-4 Trial for dry eye treatment. |
|
|
May 3, 2024 |
194 |
| HanAll Biopharma initiates Phase III VELOS-4 Trial for dry eye treatment. |
|
|
May 3, 2024 |
193 |
| Arbutus Biopharma reports Q1 EPS (10c), consensus (11c). |
|
Financial report |
May 2, 2024 |
165 |
| Parliament approves Shs578b bailout to private vaccine factory. |
|
|
May 1, 2024 |
617 |
| Validation of a New Duplex Real-Time Polymerase Chain Reaction for Chlamydia trachomatis DNA Detection in Ocular Swab Samples. |
Favacho, Joana da Felicidade Ribeiro; Leite, Keren Kariene; Jacomasso, Thiago; Farias, Aline Burda; |
|
May 1, 2024 |
11177 |
| Optimization of Composite Enzymatic Extraction, Structural Characterization and Biological Activity of Soluble Dietary Fiber from Akebia trifoliata Peel. |
Song, Ya; Sun, Guoshun; Wang, Dian; Chen, Jin; Lv, Jun; Jiang, Sixia; Zhang, Guoqiang; Yu, Shirui; Z |
|
May 1, 2024 |
9275 |
| Phenolic Compounds Profile and Antioxidant Capacity of Plant-Based Protein Supplements. |
Sawicki, Tomasz; Jablonska, Monika; Danielewicz, Anna; Przybylowicz, Katarzyna E. |
|
May 1, 2024 |
7964 |
| Dual-Task vs. Single-Task Gait Training to Improve Spatiotemporal Gait Parameters in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis. |
Sarasso, Elisabetta; Parente, Marco Pietro; Agosta, Federica; Filippi, Massimo; Corbetta, Davide |
|
May 1, 2024 |
9644 |
| Piceatannol Upregulates SIRT1 Expression in Skeletal Muscle Cells and in Human Whole Blood: In Vitro Assay and a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial. |
Tanaka, Kenta; Kawakami, Shinpei; Mori, Sadao; Yamaguchi, Takumi; Saito, Eriko; Setoguchi, Yuko; Mat |
Report |
May 1, 2024 |
8489 |
| Dried Plasma for Major Trauma: Past, Present, and Future. |
Peng, Henry T.; Singh, Kanwal; Rhind, Shawn G.; da Luz, Luis; Beckett, Andrew |
Report |
May 1, 2024 |
22545 |
| Challenges of Robust RNAi-Mediated Gene Silencing in Aedes Mosquitoes. |
Figueiredo Prates, Lucas Henrique; Fiebig, Jakob; Schlosser, Henrik; Liapi, Eleni; Rehling, Tanja; L |
|
May 1, 2024 |
16375 |
| (-)-Fenchone Prevents Cysteamine-Induced Duodenal Ulcers and Accelerates Healing Promoting Re-Epithelialization of Gastric Ulcers in Rats via Antioxidant and Immunomodulatory Mechanisms. |
Araruna, Maria Elaine Cristina; Júnior, Edvaldo Balbino Alves; Serafim, Catarina Alves de Lima; Pess |
Report |
May 1, 2024 |
8925 |
| A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule. |
Hosseini, Iraj; Fleisher, Brett; Getz, Jennifer; Decalf, Jérémie; Kwong, Mandy; Ovacik, Meric; Bainb |
|
May 1, 2024 |
9556 |
| Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties. |
Kothapalli, Yugandhar; Jones, Ransom A.; Chu, Chung K.; Singh, Uma S. |
|
May 1, 2024 |
20643 |
| Assessing the Impact of Risk Factors on Vaccination Uptake Policy Decisions Using a Bayesian Network (BN) Approach. |
Abbas, Hafiz Waqar; Sajid, Zaman; Dao, Uyen |
|
May 1, 2024 |
13879 |
| Implementing Adult Hepatitis B Immunization and Screening Using Electronic Health Records: A Practical Guide. |
Kim, H. Nina; Moore, Kelly L.; Sanders, David L.; Jackson, Michaela; Cohen, Chari; Andrews, Richard; |
Report |
May 1, 2024 |
4875 |
| Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response. |
Raccagni, Angelo Roberto; Mancon, Alessandro; Diotallevi, Sara; Lolatto, Riccardo; Bruzzesi, Elena; |
Report |
May 1, 2024 |
5609 |
| AstraZeneca admits to rare deadly side effect of COVID jab. |
|
|
Apr 30, 2024 |
535 |
| Cyclacel Pharmaceuticals to sell 4.97M shares at $1.61 in private placement. |
|
|
Apr 30, 2024 |
205 |
| Matinas BioPharma announces publication of in vivo efficacy of MAT2203. |
|
|
Apr 30, 2024 |
211 |
| Khalifa University, Mubadala, KELIX bio collaborate to advance UAE's biopharma capabilities. |
|
|
Apr 30, 2024 |
733 |
| Khalifa University, Mubadala, KELIX bio collaborate to advance UAE's biopharma capabilities. |
|
|
Apr 30, 2024 |
730 |
| LATEST COMPANY NEWS. |
|
|
Apr 30, 2024 |
12443 |
| LATEST COMPANY NEWS. |
|
|
Apr 30, 2024 |
19666 |
| CS Nakhumicha Launches First Ever Blood Delivery Drones In Kisumu. |
|
|
Apr 27, 2024 |
554 |
| Biogen receives positive CHMP opinion for TOFIDENCE. |
|
|
Apr 25, 2024 |
191 |
| Biogen announces CHMP opinion recommending Tofidence. |
|
|
Apr 25, 2024 |
183 |
| Kiromic BioPharma announces positive results in Deltacel-01 trial for NSCLC treatment. |
|
|
Apr 24, 2024 |
222 |
| Biogen reports Q1 adjusted EPS $3.67, consensus $3.44. |
|
Financial report |
Apr 24, 2024 |
188 |
| First Wave BioPharma announces publication of research on celiac disease. |
|
|
Apr 24, 2024 |
221 |
| Kiromic BioPharma announces positive results in Deltacel-01 trial for NSCLC treatment. |
|
|
Apr 24, 2024 |
223 |
| LATEST COMPANY NEWS. |
|
|
Apr 23, 2024 |
18052 |
| LATEST COMPANY NEWS. |
|
|
Apr 23, 2024 |
13554 |
| LATEST COMPANY NEWS. |
|
|
Apr 23, 2024 |
9187 |
| Xbrane Biopharma AB provides regulatory update on FDA review. |
|
|
Apr 22, 2024 |
199 |
| Xbrane Biopharma AB provides regulatory update on FDA review. |
|
|
Apr 22, 2024 |
197 |
| Xbrane Biopharma AB provides regulatory update on FDA review. |
|
|
Apr 22, 2024 |
198 |
| LATEST COMPANY NEWS. |
|
|
Apr 22, 2024 |
22201 |
| YS Biopharma's YS-HBV-002 receives Philippine clinical trial approval. |
|
|
Apr 19, 2024 |
291 |
| YS Biopharma's YS-HBV-002 receives Philippine clinical trial approval. |
|
|
Apr 19, 2024 |
290 |
| AiBtl BioPharma acquires TT Life Company. |
|
|
Apr 18, 2024 |
968 |
| Benitec Biopharma announces $40M oversubscribed private placement financing. |
|
|
Apr 18, 2024 |
236 |
| Benitec Biopharma reports interim trial data for subject treasted with BB-301. |
|
Clinical report |
Apr 18, 2024 |
246 |
| Imunon's IND application cleared to begin human testing of IMNN-101. |
|
|
Apr 18, 2024 |
156 |
| ABVC BioPharma's AiBtl BioPharma acquires TT Life Company. |
|
|
Apr 18, 2024 |
199 |
| Moderna U-turn underscores the need for vaccine independence. |
|
|
Apr 18, 2024 |
534 |
| LATEST COMPANY NEWS. |
|
|
Apr 17, 2024 |
23310 |
| Genentech reports data from OCARINA II study of Ocrevus. |
|
|
Apr 17, 2024 |
349 |
| ABVC BioPharma executes global licensing agreement for treatment of NSCLC. |
|
|
Apr 17, 2024 |
266 |
| LATEST COMPANY NEWS. |
|
|
Apr 16, 2024 |
18177 |
| LATEST COMPANY NEWS. |
|
|
Apr 16, 2024 |
13405 |
| Africa CDC faults Moderna decision on Kenya vaccine plant. |
|
|
Apr 16, 2024 |
493 |
| Genentech announces STARGLO study meets primary endpoint. |
|
|
Apr 15, 2024 |
248 |
| Like Pfizer and BioNTech, Moderna scales back its African ambitions. |
|
|
Apr 15, 2024 |
450 |
| PHAP's integrity, professionalism program trains over 6,700 pharma employees. |
|
|
Apr 15, 2024 |
426 |
| Kenya latest victim as Moderna halts Sh26bn vaccine plant. |
|
|
Apr 13, 2024 |
754 |
| Astra-nomical fat cat payout. FINANCE REVOLT AGAINST CHIEF'S PS18.5M FAILS. |
|
|
Apr 12, 2024 |
245 |
| Astra-nomical fat cat payout. mirror.co.uk/business Edited by mirror.co.uk/business FINANCE GRAHAM HISCOTT REVOLT AGAINST CHIEF'S PS18.5M FAILS. |
GRAHAM HISCOTT |
|
Apr 12, 2024 |
229 |
| Astra-nomical fat cat payout. mirror.co.uk/business Edited by mirror.co.uk/business FINANCE GRAHAM HISCOTT REVOLT AGAINST CHIEF'S PS18.5M FAILS. |
GRAHAM HISCOTT |
|
Apr 12, 2024 |
234 |
| Moderna pauses plans to build vaccines facility in Kenya. |
|
|
Apr 12, 2024 |
267 |
| Codexis appoints new member to Strategic Advisory Board. |
|
|
Apr 11, 2024 |
231 |
| Codexis appoints new member to Strategic Advisory Board. |
|
|
Apr 11, 2024 |
235 |
| MorphoSys Management, Supervisory board recommend Novartis takeover. |
|
|
Apr 11, 2024 |
234 |
| MorphoSys board recommends shareholders accept Novartis offer. |
|
|
Apr 11, 2024 |
249 |
| YS Biopharma's Phase three clinical trial of new PIKA Rabies Vaccine reveals positive interim results. |
|
|
Apr 10, 2024 |
217 |
| YS Biopharma's Phase three clinical trial of new PIKA Rabies Vaccine reveals positive interim results. |
|
|
Apr 10, 2024 |
216 |
| LATEST COMPANY NEWS. |
|
|
Apr 9, 2024 |
17647 |
| Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort. |
|
|
Apr 9, 2024 |
204 |
| Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort. |
|
|
Apr 9, 2024 |
205 |
| Waters introduces Alliance iS Bio HPLC System to boost biopharma QC efficiency. |
|
|
Apr 9, 2024 |
166 |
| YS Biopharma's PIKA Rabies Vaccine meets Phase 3 primary endpoints. |
|
|
Apr 9, 2024 |
179 |
| Whooping cough: Inside country where vaccines are running out as medics fear huge death toll; In the Philippines there have been 49 infant fatalities from whooping cough since the start of January, with the government fearing the situation may worsen as doctors will be left without vaccines for a whole month. |
By, Ryan Fahey |
|
Apr 9, 2024 |
791 |
| Palatin presents results from Phase 3 PL9643 MELODY-1 trial. |
|
|
Apr 8, 2024 |
448 |
| Nigerian Manufacturers Capable Of Producing Vaccines, Tinubu Tells GAVI. |
|
|
Apr 7, 2024 |
246 |
| Nigerian Manufacturers Capable Of Producing Vaccines, Tinubu Tells GAVI. |
|
|
Apr 6, 2024 |
246 |
| Tinubu to GAVI CEO: Nigeria's Ability to Produce Vaccines Not in Doubt. |
|
|
Apr 5, 2024 |
559 |
| Nigerian Manufacturers Capable Of Producing Vaccines, Tinubu Tells GAVI. |
|
|
Apr 5, 2024 |
246 |
| Nigerian Manufacturers Ready To Produce Vaccines- President Tinubu To Gavi CEO. |
|
|
Apr 5, 2024 |
571 |
| Tinubu to GAVI: Nigerian manufacturers capable, ready to produce vaccines. |
|
|
Apr 5, 2024 |
550 |
| Tinubu Seeks GAVI's Collaboration With Indigenous Vaccine Manufacturers. |
|
|
Apr 5, 2024 |
345 |
| Work with Nigerians to produce vaccines, Tinubu tells GAVI. |
|
|
Apr 4, 2024 |
547 |
| Nigerian Manufacturers Capable, Ready To Produce Vaccines - Tinubu. |
|
|
Apr 4, 2024 |
574 |
| Nigerian manufacturers capable of producing vaccines, Tinubu tells GAVI. |
|
|
Apr 4, 2024 |
557 |
| ARCA Biopharma, Oruka Therapeutics enter merger agreement. |
|
|
Apr 3, 2024 |
601 |
| Matinas BioPharma prices 33.33M shares at 30c in registered direct offering. |
|
|
Apr 3, 2024 |
167 |
| YS Biopharma repays USD40m loan facility. |
|
|
Apr 3, 2024 |
221 |
| YS Biopharma repays USD40m loan facility. |
|
|
Apr 3, 2024 |
220 |
| LATEST COMPANY NEWS. |
|
|
Apr 2, 2024 |
13300 |
| LATEST COMPANY NEWS. |
|
|
Apr 2, 2024 |
18322 |
| RedHill Biopharma to sell 2.14M ADSs at 58.289c in registered direct offering. |
|
|
Apr 2, 2024 |
201 |
| Nurix Therapeutics announces extension of collaboration with Gilead. |
|
|
Apr 2, 2024 |
204 |
| Acorda Therapeutics, Merz sign "stalking horse" asset purchase deal for $185M. |
|
|
Apr 1, 2024 |
175 |
| 3-Methyl-4-nitrophenol Exposure Deteriorates Oocyte Maturation by Inducing Spindle Instability and Mitochondrial Dysfunction. |
Chen, Fan; Luo, An-Feng; Li, Ming-Guo; Zheng, Li-Xiang; Gu, Hao; Zhou, Chang-Fan; Zeng, Wei; Molenaa |
|
Apr 1, 2024 |
6317 |
| The Use of Tenofovir Disoproxil Fumarate in the Management of eAg-Negative Chronic Hepatitis B Infection. |
Jagarlamudi, Nishita; Reyes, Melissa; Fung, Scott; Wong, Florence |
Report |
Apr 1, 2024 |
6129 |
| Characterization of the First Secreted Sorting Nexin Identified in the Leishmania Protists. |
Tziouvara, Olympia; Petsana, Marina; Kourounis, Drosos; Papadaki, Amalia; Basdra, Efthimia; Braliou, |
|
Apr 1, 2024 |
14285 |
| High-Value Compounds in Papaya By-Products (Carica papaya L. var. Formosa and Aliança): Potential Sustainable Use and Exploitation. |
Vinha, Ana F.; Costa, Anabela S. G.; Espírito Santo, Liliana; Ferreira, Diana M.; Sousa, Carla; Pint |
Report |
Apr 1, 2024 |
10024 |
| Nanoemulsions Containing Passiflora quadrangularis L. Fruit Extracts for Cosmetic Application and Skin Efficacy Study. |
Yanasan, Nareekan; Wangkananon, Worrapon; Natakankitkul, Surapol; Kiattisin, Kanokwan |
Report |
Apr 1, 2024 |
7514 |
| The Canadian Breast Cancer Symposium 2023 Meeting Report. |
Cil, Tulin; Boileau, Jean-François; Chia, Stephen; DeCoteau, MJ; Jerzak, Katarzyna J.; Koch, Anne; N |
Report |
Apr 1, 2024 |
17082 |
| Disease Burden and Inpatient Management of Children with Acute Respiratory Viral Infections during the Pre-COVID Era in Germany: A Cost-of-Illness Study. |
Alchikh, Maren; Conrad, Tim O. F.; Obermeier, Patrick E.; Ma, Xiaolin; Schweiger, Brunhilde; Opota, |
Report |
Apr 1, 2024 |
11400 |
| Development and Application of Attenuated Plant Viruses as Biological Control Agents in Japan. |
Tomitaka, Yasuhiro; Shimomoto, Yoshifumi; Ryang, Bo-Song; Hayashi, Kazusa; Oki, Tomoka; Matsuyama, M |
Report |
Apr 1, 2024 |
7181 |
| No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. |
Hedskog, Charlotte; Spinner, Christoph D.; Protzer, Ulrike; Hoffmann, Dieter; Ko, Chunkyu; Gottlieb, |
Report |
Apr 1, 2024 |
7898 |
| Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. |
Hurwitz, Selwyn J.; De, Ramyani; LeCher, Julia C.; Downs-Bowen, Jessica A.; Goh, Shu Ling; Zandi, Ke |
Report |
Apr 1, 2024 |
16674 |
| Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia. |
Shakinah, Sharifah; Aini, Muhammad Hafiz; Sekartini, Rini; Soedjatmiko; Medise, Bernie Endyarni; Gun |
Report |
Apr 1, 2024 |
6688 |
| Mechanism of Mulberry Leaves and Black Sesame in Alleviating Slow Transit Constipation Revealed by Multi-Omics Analysis. |
Sun, Chen; Wang, Zheng; Tan, Yang; Li, Ling; Zhou, Feng; Hu, Shi-An; Yan, Qin-Wen; Li, Lin-Hui; Pei, |
|
Apr 1, 2024 |
10147 |
| New Pyranone Derivatives and Sesquiterpenoid Isolated from the Endophytic Fungus Xylaria sp. Z184. |
Zhang, Yan; Jin, Yang; Yan, Wensi; Gu, Peishan; Zeng, Ziqian; Li, Ziying; Zhang, Guangtao; Wei, Mi; |
|
Apr 1, 2024 |
7391 |
| Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D. |
Gherlan, George S.; Lazar, Stefan D.; Culinescu, Augustina; Smadu, Dana; Vatafu, Andreea R.; Popescu |
|
Apr 1, 2024 |
4569 |
| Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids. |
Chiesa, Enrica; Caimi, Alessandro; Bellotti, Marco; Giglio, Alessia; Conti, Bice; Dorati, Rossella; |
|
Apr 1, 2024 |
10696 |
| Eisai, Biogen announce sBLA submission for monthly LEQEMBI IV maintenance dosing. |
|
|
Mar 31, 2024 |
271 |
| Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301. |
|
|
Mar 28, 2024 |
313 |
| Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301. |
|
|
Mar 28, 2024 |
233 |
| AbbVie to Acquire Landos Biopharma for USD 137.5m. |
|
|
Mar 26, 2024 |
197 |
| AbbVie to Acquire Landos Biopharma for USD 137.5m. |
|
|
Mar 26, 2024 |
174 |
| ABVC BioPharma enters into global licensing deal with ForSeeCon Eye. |
|
|
Mar 26, 2024 |
248 |
| LATEST COMPANY NEWS. |
|
|
Mar 26, 2024 |
18764 |
| LATEST COMPANY NEWS. |
|
|
Mar 26, 2024 |
9260 |
| LATEST COMPANY NEWS. |
|
|
Mar 26, 2024 |
13501 |
| LATEST COMPANY NEWS. |
|
|
Mar 26, 2024 |
10031 |
| African Pharmaceutical Technology Foundation and Pharmaceutical Institute partner to strengthen Nigeria's pharmaceutical and vaccine manufacturing capacity. |
|
|
Mar 26, 2024 |
393 |
| Egypt to complete building 1st factory for bird flu vaccines in 90 days: Official. |
|
|
Mar 26, 2024 |
586 |
| LATEST COMPANY NEWS. |
|
|
Mar 25, 2024 |
6376 |
